Szatmári, S.; Szász, J.A.; Orbán-Kis, K.; Baróti, B.; Bataga, S.; Ciorba, M.; Nagy, E.E.; Neagoe, R.M.; Mihály, I.; Szász, P.Z.;
et al. Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience. Pharmaceutics 2024, 16, 453.
https://doi.org/10.3390/pharmaceutics16040453
AMA Style
Szatmári S, Szász JA, Orbán-Kis K, Baróti B, Bataga S, Ciorba M, Nagy EE, Neagoe RM, Mihály I, Szász PZ,
et al. Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience. Pharmaceutics. 2024; 16(4):453.
https://doi.org/10.3390/pharmaceutics16040453
Chicago/Turabian Style
Szatmári, Szabolcs, József Attila Szász, Károly Orbán-Kis, Beáta Baróti, Simona Bataga, Marius Ciorba, Előd Ernő Nagy, Radu Mircea Neagoe, István Mihály, Péter Zsombor Szász,
and et al. 2024. "Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience" Pharmaceutics 16, no. 4: 453.
https://doi.org/10.3390/pharmaceutics16040453
APA Style
Szatmári, S., Szász, J. A., Orbán-Kis, K., Baróti, B., Bataga, S., Ciorba, M., Nagy, E. E., Neagoe, R. M., Mihály, I., Szász, P. Z., Kelemen, K., Frigy, A., Szilveszter, M., & Constantin, V. A.
(2024). Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience. Pharmaceutics, 16(4), 453.
https://doi.org/10.3390/pharmaceutics16040453
